Insulet Corp. closed 7.87% below its 52-week high of $289.46, which the company achieved on February 7th.

Insulet (NASDAQ:PODD – Get Free Report) was upgraded by StockNews.com from a “hold” rating to a “buy” rating in a research ...

Insulet Corporation (PODD), headquartered in Acton, Massachusetts, operates as an innovative medical device company. Valued ...

Insulin delivery company Insulet Corporation (NASDAQ:PODD) reported Q4 CY2024 results , with sales up 17.2% year on year to ...

Investors eyeing a purchase of Insulet Corp (Symbol: PODD) stock, but cautious about paying the going market price of $285.98/share, might benefit from considering selling puts among the ...

Stock analysts at Leerink Partnrs lowered their Q1 2025 earnings per share (EPS) estimates for Insulet in a research note ...

Insulet Corporation (PODD) continues its strong sales and growth trend.

Insulet Corporation (NASDAQ:PODD) reported fourth-quarter adjusted EPS of $1.15, down from $1.40 a year ago but beating the ...

Learn more about whether Koninklijke Philips N.V. or Insulet Corporation is a better investment based on AAII's A+ Investor ...

Investors eyeing a purchase of Insulet Corp (Symbol: PODD) shares, but tentative about paying the going market price of $286.60/share, might benefit from considering selling puts among the ...

Good afternoon ladies and gentlemen and welcome to the Insulet Corporation Fourth Quarter and Full Year 2024 Earnings Call. At this time all participants are in a listen-only mode. Later we will ...

Shares of Insulet Corp. PODD slid 1.90% to $282.80 Friday, on what proved to be an all-around dismal trading session for the ...